싸이토젠

Research Areas

By utilizing Cytogen’s differentiated CTC isolation technology, we are dedicated to developing liquid biopsy technologies that lead future innovations through research in precision medicine, personalized medicine, and anti-metastatic mechanisms across various fields of basic and clinical medicine.

Clinical Research

Development of early diagnosis technology for blood cancer
Research on indication-specific liquid biopsy methods for early diagnosis of various solid tumors
Research on companion diagnostic technology for anticancer drug selection through liquid biopsy
Research on identifying new diagnostic biomarkers specific to liquid biopsy

Basic Research

Research on tracking drug response changes through CTC culture
Basic research on exploring cancer metastasis mechanisms using CTCs
Research on exploring cancer metastasis mechanisms using animal models

Clinical Diagnostic Research Fields

Diagnosis and Prognosis Prediction of Multiple Myeloma

We research applications for the diagnosis and prognosis prediction of multiple myeloma through the recovery and analysis of myeloma cells in the blood.

Companion Diagnostic Research for Prostate Cancer

We research companion diagnostics through liquid biopsy to realize personalized treatment by selecting suitable anticancer drugs for prostate cancer patients.

CTC Analysis Research for Recurrence and Metastasis Detection in Post-Treatment Breast Cancer Patients

For patients with detected recurrence and metastasis after treatment, we research diagnostic methods that can predict prognosis through liquid biopsy.

Research on Identifying New CTC Biomarkers for Pancreatic Cancer

We research the identification of biomarkers for early diagnosis through liquid biopsy for pancreatic cancer, a cancer type for which tissue biopsy is difficult.

Basic Research

Research on Exploring Cancer Metastasis Mechanisms Using Preclinical Models

To understand the molecular mechanisms of Circulating Tumor Cells (CTCs), a major factor in cancer metastasis, we study cancer metastasis using animal models.

Research on Establishing CTC Culture Methods

For a wider range of CTC applications, we research culture methods at a level that can substitute for tissue biopsies.

Research on New CTC Detection Methods

We conduct research to minimize undetected circulating tumor cells by analyzing various characteristics of CTCs in very small amount in the blood from various angles.

Research on Identifying New CTC Biomarkers for Pancreatic Cancer

We continue to study ways to recover circulatory tumor cells that exist in very small amounts in the blood with minimal loss.